Vetoquinol Universal Registration Document 2019

Vetoquinol  Universal Registration Document 2019  Financial report   75 CONSOLIDATED FINANCIAL STATEMENTS Notes to the consolidated financial statements 6 6.5.12 Share-based payments – bonus shares There was no bonus share plan outstanding at 2019 year-end, as in the previous year. 6.5.13 Other operating income and expenses €000 2019 2018 Operating grants 15 29 Investment grants transferred to income for the year 8 11 Gains on asset sales 678 279 Research tax credit (Crédit d’Impôt Recherche - CIR) 3,839 4,504 Other income 1,504 1,376 OTHER OPERATING INCOME 6,043 6,199 Book values of assets sold (836) (167) Other expenses (646) (810) OTHER OPERATING EXPENSES (1,483) (977) TOTAL 4,560 5,223 Other expenses included bad debt losses of €0.3 million. In 2018, other expenses included bad debt losses of €0.3 million. Other income consists of: €000 2019 2018 Fees and royalties - - Freight costs passed on to customers 362 447 Compensation received 53 14 Social security refunds - 2 Other 1,089 914 TOTAL 1,504 1,376 6.5.14 Non-recurring operating income and expenses €000 2019 2018 Non-recurring operating income - 16 Impairment of intangible assets (France) (3,502) (100) Restructuring costs (Italy) (1,516) - Restructuring costs (Canada) - (131) Other non-recurring operating expenses (5,018) (231) TOTAL (5,018) (215)